IL239623A0 - Methods and compositions for admisitration of oxybutynin - Google Patents
Methods and compositions for admisitration of oxybutyninInfo
- Publication number
- IL239623A0 IL239623A0 IL239623A IL23962315A IL239623A0 IL 239623 A0 IL239623 A0 IL 239623A0 IL 239623 A IL239623 A IL 239623A IL 23962315 A IL23962315 A IL 23962315A IL 239623 A0 IL239623 A0 IL 239623A0
- Authority
- IL
- Israel
- Prior art keywords
- admisitration
- oxybutynin
- compositions
- methods
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Otolaryngology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/728,706 US9119777B2 (en) | 2008-05-30 | 2012-12-27 | Methods and compositions for administration of oxybutynin |
| PCT/US2013/074759 WO2014105446A1 (en) | 2012-12-27 | 2013-12-12 | Methods and compositions for administration of oxybutynin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL239623A0 true IL239623A0 (en) | 2015-08-31 |
Family
ID=51021931
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL239623A IL239623A0 (en) | 2012-12-27 | 2015-06-24 | Methods and compositions for admisitration of oxybutynin |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP2938329A4 (en) |
| JP (1) | JP2016504358A (en) |
| KR (1) | KR20150100902A (en) |
| CN (1) | CN104955444A (en) |
| AR (1) | AR094287A1 (en) |
| AU (1) | AU2013368298B2 (en) |
| BR (1) | BR112015015421A2 (en) |
| CA (1) | CA2895955A1 (en) |
| EA (1) | EA201591218A1 (en) |
| HK (2) | HK1215396A1 (en) |
| IL (1) | IL239623A0 (en) |
| MX (1) | MX2015008333A (en) |
| NZ (1) | NZ628479A (en) |
| UY (1) | UY35230A (en) |
| WO (1) | WO2014105446A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190046493A1 (en) * | 2016-02-25 | 2019-02-14 | Hisamitsu Pharmaceutical Co., Inc. | Liquid external preparation |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2371923A1 (en) * | 1999-05-20 | 2000-11-30 | Thomas P. Jerussi | Methods for treatment of asthma using s-oxybutynin |
| US6339107B1 (en) * | 2000-08-02 | 2002-01-15 | Syntex (U.S.A.) Llc | Methods for treatment of Emphysema using 13-cis retinoic acid |
| EP1558563A1 (en) * | 2002-10-29 | 2005-08-03 | Pharmacia & Upjohn Company LLC | Quaternary ammonium compounds |
| GB0410398D0 (en) * | 2004-05-10 | 2004-06-16 | Arakis Ltd | The treatment of respiratory disease |
| US20060110449A1 (en) * | 2004-10-25 | 2006-05-25 | Lorber Richard R | Pharmaceutical composition |
| US8415390B2 (en) * | 2008-05-30 | 2013-04-09 | Microdose Therapeutx, Inc. | Methods and compositions for administration of oxybutynin |
| EP2257172A4 (en) * | 2008-02-26 | 2013-07-03 | Elevation Pharmaceuticals Inc | Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations |
| WO2010147631A1 (en) * | 2009-06-16 | 2010-12-23 | Wen Tan | Use of r-bambuterol as inhaled medicament and combination therapies for treatment of respiratory disorders |
| GB0918450D0 (en) * | 2009-10-21 | 2009-12-09 | Innovata Ltd | Composition |
| EP2762133A1 (en) * | 2010-04-01 | 2014-08-06 | CHIESI FARMACEUTICI S.p.A. | Process for preparing carrier particles for dry powders for inhalation |
| WO2012047674A2 (en) * | 2010-09-27 | 2012-04-12 | Microdose Therapeutx, Inc. | Methods and compositions for disease treatment using inhalation |
-
2013
- 2013-12-12 NZ NZ628479A patent/NZ628479A/en not_active IP Right Cessation
- 2013-12-12 CN CN201380068230.5A patent/CN104955444A/en active Pending
- 2013-12-12 BR BR112015015421A patent/BR112015015421A2/en not_active IP Right Cessation
- 2013-12-12 MX MX2015008333A patent/MX2015008333A/en unknown
- 2013-12-12 CA CA2895955A patent/CA2895955A1/en not_active Abandoned
- 2013-12-12 KR KR1020157020335A patent/KR20150100902A/en not_active Application Discontinuation
- 2013-12-12 JP JP2015550444A patent/JP2016504358A/en active Pending
- 2013-12-12 EP EP13867956.8A patent/EP2938329A4/en not_active Withdrawn
- 2013-12-12 WO PCT/US2013/074759 patent/WO2014105446A1/en active Application Filing
- 2013-12-12 AU AU2013368298A patent/AU2013368298B2/en not_active Ceased
- 2013-12-12 EA EA201591218A patent/EA201591218A1/en unknown
- 2013-12-20 UY UY0001035230A patent/UY35230A/en not_active Application Discontinuation
- 2013-12-27 AR ARP130105037A patent/AR094287A1/en unknown
-
2015
- 2015-06-24 IL IL239623A patent/IL239623A0/en unknown
-
2016
- 2016-03-23 HK HK16103431.3A patent/HK1215396A1/en unknown
- 2016-04-25 HK HK16104715.8A patent/HK1216843A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR112015015421A2 (en) | 2017-07-11 |
| EP2938329A4 (en) | 2016-08-10 |
| EP2938329A1 (en) | 2015-11-04 |
| EA201591218A1 (en) | 2015-11-30 |
| HK1215396A1 (en) | 2016-08-26 |
| AR094287A1 (en) | 2015-07-22 |
| UY35230A (en) | 2015-01-30 |
| MX2015008333A (en) | 2015-11-09 |
| CN104955444A (en) | 2015-09-30 |
| HK1216843A1 (en) | 2016-12-09 |
| CA2895955A1 (en) | 2014-07-03 |
| KR20150100902A (en) | 2015-09-02 |
| JP2016504358A (en) | 2016-02-12 |
| AU2013368298B2 (en) | 2016-08-11 |
| WO2014105446A1 (en) | 2014-07-03 |
| NZ628479A (en) | 2016-06-24 |
| AU2013368298A1 (en) | 2015-07-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1251246A1 (en) | Methods and compositions for desulfurization of compositions | |
| IL272539B (en) | Compositions and methods for immunotherapy | |
| AP3965A (en) | Anthelminitic compounds and compositions and method of using thereof | |
| HK1204330A1 (en) | Factor viii compositions and methods of making and using same viii | |
| ZA201508059B (en) | Compositions and methods of use of phorbol esters | |
| EP2836224A4 (en) | Compositions of microbiota and methods related thereto | |
| EP2834322A4 (en) | Biochar compositions and methods of use thereof | |
| EP2675471A4 (en) | Hsa-related compositions and methods of use | |
| EP2836212A4 (en) | Novel compositions and methods | |
| ZA201408594B (en) | Xylitol-based anti-mucosal compositions and related methods and compositions | |
| EP2917314A4 (en) | Composition of oligomerate | |
| IL227924A0 (en) | Compositions and methods of use for determination of he4a | |
| EP2672822A4 (en) | Methods and compositions for improving cognitive function | |
| EP2906041A4 (en) | Compositions and methods of use of an inappetance-controlling compound | |
| EP2931280A4 (en) | Methods and compositions for inhibiting cnksr1 | |
| EP2867199A4 (en) | Stable compositions of fesoterodine | |
| EP2852662A4 (en) | Herpesvirus compositions and related methods | |
| IL239623A0 (en) | Methods and compositions for admisitration of oxybutynin | |
| HK1212998A1 (en) | Ron compositions and methods of use thereof ron | |
| EP2841164A4 (en) | Dermal-appropriate compositions and methods of use |